IP Library › Granted Patent US 12,637,438
Granted Patent B2
US 12,637,438 · App. 18/234,250 · Granted May 26, 2026

Protoporphyrinogen oxidase inhibitors

Inventors: Neville John Anthony (Northborough, MA); Paul Galatsis (Newton, MA); David Jeffrey Lauffer (Stow, MA); Peter Stchur, III (Waterford, CT)
Assignee: Enko Chem, Inc.
C07D265/38A01N43/84A01P13/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,637,438
App. No.
18/234,250
Granted
May 26, 2026
Kind
B2
Abstract

The present invention relates to protoporphyrinogen oxidase inhibitors of the general formula (I) where the variables are defined herein. The invention features processes and intermediates for preparing the benzoxazinones of formula (I), compositions comprising them, and their use as herbicides—i.e. for controlling harmful plants. The invention also features methods for controlling unwanted vegetation comprising allowing an herbicidal effective amount of at least one benzoxazinone of formula (I) to act on plants, their seed, and/or their habitat.

Claims (87)

1 . A method of controlling undesired vegetation, wherein the undesired vegetation comprises protoporphyrinogen IX oxidase (PPO) inhibitor-resistant weeds, the method comprising contacting the undesired vegetation or its environment with an herbicidally effective amount of a composition comprising a compound of formula I:

or a salt thereof, wherein:

R 1 is H or C 1-4 alkyl optionally substituted with R 1a , phenyl, or benzyl, wherein each of said alkyl, phenyl or benzyl is optionally substituted with up to 3 F atoms, an OH group, or an OC 1-4 alkyl group;

R 1a is

each R 1b is, independently, H, C 1-4 alkyl, or cyclopropyl;

each of R 2 and R 3 is, independently, H, Cl, F, CH 3 , or R 2 and R 3 together with the intervening carbon is cyclopropyl;

R 4 is H, Cl, or F;

R 5 is H or F;

each of R 6 and R 7 is, independently, F, H, C 1-2 alkyl optionally substituted with OH, alkenyl, OH, OC 1-2 alkyl, O-cyclopropyl, OCH 2 CCH, NHCH 2 Ph, N(R x ) 2 , or SCH 3 ;

R 8 is H or F;

each R x is, independently, H, CH 3 , or C(O)CH 3 ; and

wherein Ring A contains at least 4 F atom substituents.

2 . The method of claim 1 , wherein the compound is of formula II:

or a salt thereof, wherein R 1 , R 2 , R 3 , and R 4 are as defined in formula I.

3 . The method of claim 1 , wherein the compound is of formula III:

or a salt thereof, wherein R 1 , R 2 , R 3 , and R 4 are as defined in formula I.

4 . The method of claim 1 , wherein the compound is of formula IV:

or a salt thereof, wherein R 1 , R 2 , R 3 , and R 4 are as defined in formula I.

5 . The method of claim 1 , wherein each of R 2 , R 3 , and R 4 is F.

6 . The method of claim 1 , wherein each of R 2 and R 3 is H and R 4 is F.

7 . The method of claim 1 , wherein each of R 2 , R 3 , and R 4 is F, and R 1 is CH 2 CCH.

8 . The method of claim 1 , wherein the composition further comprises at least one additional component that serves as a carrier.

9 . The method of claim 8 , wherein the at least one additional component in the composition is a surfactant or a diluent.

10 . The method of claim 1 , wherein the composition is an herbicidal composition.

11 . The method of claim 1 , wherein the PPO inhibitor-resistant weeds have a dG210 mutation.

12 . The method of claim 1 , wherein the composition is applied at a rate of 1 to 100 g per 10,000 m 2 .

13 . The method of claim 1 , wherein the contacting the undesired vegetation or its environment with the composition leads to postemergence control of the undesired vegetation.

14 . The method of claim 1 , wherein the undesired vegetation is at least 60% controlled.

15 . The method of claim 1 , wherein the undesired vegetation is controlled in a field of corn, soybean, wheat and/or cotton.

16 . The method of claim 1 , wherein the contacting the undesired vegetation or its environment with the composition leads to preemergence control of the undesired vegetation.

17 . A method of controlling undesired vegetation, wherein the undesired vegetation comprises protoporphyrinogen IX oxidase (PPO) inhibitor-resistant weeds, the method comprising contacting the undesired vegetation or its environment with an herbicidally effective amount of a compound selected from the group consisting of

or a salt thereof.

18 . The method of claim 17 , wherein the compound is:

or a salt thereof.

19 . A method of preparing a compound of formula (I):

or a salt thereof, wherein:

R 1 is H or C 1-4 alkyl optionally substituted with R 1a , phenyl, or benzyl, wherein each of said alkyl, phenyl or benzyl is optionally substituted with up to 3 F atoms, an OH group, or an OC 1-4 alkyl group;

R 1a is

each R 1b is, independently, H, C 1-4 alkyl, or cyclopropyl;

each of R 2 and R 3 is, independently, H, Cl, F, CH 3 , or R 2 and R 3 together with the intervening carbon is cyclopropyl;

R 4 is H, Cl, or F;

R 5 is H or F;

each of R 6 and R 7 is, independently, F, H, C 1-2 alkyl optionally substituted with OH, alkenyl, OH, OC 1-2 alkyl, O-cyclopropyl, OCH 2 CCH, NHCH 2 Ph, N(R x ) 2 , or SCH 3 ;

R 8 is H or F;

each R x is, independently, H, CH 3 , or C(O)CH 3 ; and

wherein Ring A contains at least 4 F atom substituents,

the method comprising:

i) deprotecting a compound of formula (c), or a salt thereof, to yield a compound of formula (d), or a salt thereof,

ii) reducing the compound of formula (d), or a salt thereof, to yield a compound of formula (e), or a salt thereof,

iii) reacting the compound of formula (e), or a salt thereof, with a compound of formula (f), or a salt thereof, to yield a compound of formula (g), or a salt thereof,

iv) cyclizing the compound of formula (g), or a salt thereof, to yield a compound of formula (h), or a salt thereof,

 and

when R 1 is other than H, the method further comprises:

v) reacting the compound of formula (h), or a salt thereof, with a compound of formula (i), or a salt thereof, to yield the compound of formula (I), or a salt thereof,

wherein:

Y is X or B (OH) 2;

X is Br or I; and

R 1 -R 8 and ring A are as defined for formula (I).

20 . A method of preparing a compound of formula (I):

or a salt thereof, wherein:

R 1 is H or C 1-4 alkyl optionally substituted with R 1a , phenyl, or benzyl, wherein each of said alkyl, phenyl or benzyl is optionally substituted with up to 3 F atoms, an OH group, or an OC 1-4 alkyl group;

R 1a is

each R 1b is, independently, H, C 1-4 alkyl, or cyclopropyl;

each of R 2 and R 3 is, independently, H, Cl, F, CH 3 , or R 2 and R 3 together with the intervening carbon is cyclopropyl;

R 4 is H, Cl, or F;

R 5 is H or F;

each of R 6 and R 7 is, independently, F, H, C 1-2 alkyl optionally substituted with OH, alkenyl, OH, OC 1-2 alkyl, O-cyclopropyl, OCH 2 CCH, NHCH 2 Ph, N(R x ) 2 , or SCH 3 ;

R 8 is H or F;

each R x is, independently, H, CH 3 , or C(O)CH 3 ; and

wherein Ring A contains at least 4 F atom substituents,

the method comprising reacting a compound of formula (n), or a salt thereof, with a compound of formula (o), or a salt thereof, to form the compound of formula (I), or a salt thereof,

wherein:

R is H or phenyl;

X is Br or I; and

R 1 -R 8 and ring A are as defined for formula (I).

21 . A compound of formula (c), (d), (e), (g), or (h):

or a salt thereof, wherein:

each of R 2 and R 3 is, independently, H, Cl, F, CH 3 , or R 2 and R 3 together with the intervening carbon is cyclopropyl;

R 4 is H, Cl, or F;

R 5 is H or F;

each of R 6 and R 7 is, independently, F, H, C 1-2 alkyl optionally substituted with OH, alkenyl, OH, OC 1-2 alkyl, O-cyclopropyl, OCH 2 CCH, NHCH 2 Ph, N(R x ) 2 , or SCH 3 ;

R 8 is H or F;

each R x is, independently, H, CH 3 , or C(O)CH 3 ; and

wherein Ring A contains at least 4 F atom substituents,

wherein the compound is not

22 . The compound of claim 21 , wherein the compound is of formula (d), (e), (g), or (h):

or a salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2025
From: ANTHONY, NEVILLE JOHN; GALATSIS, PAUL; LAUFFER, DAVID JEFFREY; STCHUR, PETER, III
To: ENKO CHEM, INC.
Reel/Frame 072571/0888 →
Continuity (6)
Continuation 18122583 · Mar 16, 2023
Continuation PCTUS2022076458 · Sep 15, 2022
Provisional Application 63400365 · Aug 23, 2022
Provisional Application 63299855 · Jan 14, 2022
Provisional Application 63244586 · Sep 15, 2021
Related Publication 20230382876A1 · Nov 30, 2023
References Cited (300)
US 2891855A · Hans et al. · 1959 [cited by applicant]
US 3060084A · Littler · 1962 [cited by applicant]
US 3235361A · Loux · 1966 [cited by applicant]
US 3299566A · Macmullen · 1967 [cited by applicant]
US 3309192A · Luckenbaugh · 1967 [cited by applicant]
US 3920442A · Albert et al. · 1975 [cited by applicant]
US 4144050A · Frensch et al. · 1979 [cited by applicant]
US 4172714A · Albert · 1979 [cited by applicant]
US 4514574A · Inoue et al. · 1985 [cited by applicant]
US 4640707A · Nagano et al. · 1987 [cited by applicant]
US 4761373A · Anderson et al. · 1988 [cited by applicant]
US 4782086A · Lunkenheimer et al. · 1988 [cited by applicant]
US 4816533A · McLean et al. · 1989 [cited by applicant]
US 4940835A · Shah et al. · 1990 [cited by applicant]
US 5013659A · Bedbrook et al. · 1991 [cited by applicant]
US 5180587A · Moore · 1993 [cited by applicant]
US 5188642A · Shah et al. · 1993 [cited by applicant]
US 5208030A · Hoy et al. · 1993 [cited by applicant]
US 5232701A · Ogawa et al. · 1993 [cited by applicant]
US 5304732A · Anderson et al. · 1994 [cited by applicant]
US 5561236A · Leemans et al. · 1996 [cited by applicant]
US 5608147A · Kaphammer · 1997 [cited by applicant]
US 5627061A · Barry et al. · 1997 [cited by applicant]
US 5633435A · Barry et al. · 1997 [cited by applicant]
US 5646024A · Leemans et al. · 1997 [cited by applicant]
US 5670454A · Grossmann et al. · 1997 [cited by applicant]
US 5804425A · Barry et al. · 1998 [cited by applicant]
US 6100446A · Streber et al. · 2000 [cited by applicant]
US 6153401A · Streber et al. · 2000 [cited by applicant]
US 6211438B1 · Anderson et al. · 2001 [cited by applicant]
US 6211439B1 · Anderson et al. · 2001 [cited by applicant]
US 6222100B1 · Anderson et al. · 2001 [cited by applicant]
US 6376754B1 · Schillinger et al. · 2002 [cited by applicant]
US 6791014B2 · Garcon et al. · 2004 [cited by applicant]
US 7105724B2 · Weeks et al. · 2006 [cited by applicant]
US 7384967B2 · Polisetti et al. · 2008 [cited by applicant]
US 7842686B2 · Anderson et al. · 2010 [cited by applicant]
US 7897628B2 · Polisetti et al. · 2011 [cited by applicant]
US 8063081B2 · Polisetti et al. · 2011 [cited by applicant]
US 8237002B2 · Asaumi et al. · 2012 [cited by applicant]
US 8669208B2 · Newton et al. · 2014 [cited by applicant]
US 8846742B2 · Ambron et al. · 2014 [cited by applicant]
US RE45670E · Polisetti et al. · 2015 [cited by applicant]
US 9220268B2 · Witschel et al. · 2015 [cited by applicant]
US 9359312B2 · Dochnahl et al. · 2016 [cited by applicant]
US 9402826B2 · Ambron et al. · 2016 [cited by applicant]
US 9487529B2 · Breslin et al. · 2016 [cited by applicant]
US 10026906B2 · Jung et al. · 2018 [cited by applicant]
US 10584093B2 · Jia et al. · 2020 [cited by applicant]
US 11827610B2 · Neville et al. · 2023 [cited by applicant]
US 11889833B2 · Neville et al. · 2024 [cited by applicant]
US 20030217381A1 · Croughan · 2003 [cited by applicant]
US 20040158065A1 · Barth et al. · 2004 [cited by applicant]
US 20050209242A1 · Chen · 2005 [cited by applicant]
US 20060019967A1 · Wu et al. · 2006 [cited by applicant]
US 20060094747A1 · Van Zandt et al. · 2006 [cited by applicant]
US 20060141377A1 · Kuboshima et al. · 2006 [cited by applicant]
US 20060160005A1 · Kuboshima et al. · 2006 [cited by applicant]
US 20060224011A1 · Ishikawa et al. · 2006 [cited by applicant]
US 20070054209A1 · Azuma et al. · 2007 [cited by applicant]
US 20070078129A1 · Lagu et al. · 2007 [cited by applicant]
US 20080153020A1 · Hamasaki et al. · 2008 [cited by applicant]
US 20080293739A1 · Trede · 2008 [cited by applicant]
US 20090076266A1 · Daugulis et al. · 2009 [cited by applicant]
US 20100258765A1 · Dabrowski et al. · 2010 [cited by applicant]
US 20130184155A1 · Newton et al. · 2013 [cited by applicant]
US 20140171525A1 · Yu et al. · 2014 [cited by applicant]
US 20150250181A1 · Witschel et al. · 2015 [cited by applicant]
US 20160133845A1 · Jung et al. · 2016 [cited by applicant]
US 20160204353A1 · Jung et al. · 2016 [cited by applicant]
US 20160206605A1 · Madden et al. · 2016 [cited by applicant]
US 20190100486A1 · Jia et al. · 2019 [cited by applicant]
US 20200054014A1 · Kraus et al. · 2020 [cited by applicant]
US 20200187499A1 · Hoffmann et al. · 2020 [cited by applicant]
US 20200259103A1 · Park · 2020 [cited by applicant]
US 20200295269A1 · Lee et al. · 2020 [cited by applicant]
US 20200313096A1 · Kim et al. · 2020 [cited by applicant]
US 20210392888A1 · Satchivi et al. · 2021 [cited by applicant]
US 20230265060A1 · Neville et al. · 2023 [cited by applicant]
US 20230354809A1 · Neville et al. · 2023 [cited by applicant]
US 20240130365A1 · Neville et al. · 2024 [cited by applicant]
US 20250084044A1 · Neville et al. · 2025 [cited by applicant]
CN 1952792A · 2007 [cited by applicant]
CN 101463019A · 2009 [cited by applicant]
CN 102086179A · 2011 [cited by applicant]
CN 102153429A · 2011 [cited by applicant]
CN 102241553A · 2011 [cited by applicant]
CN 102464611A · 2012 [cited by applicant]
CN 102731317A · 2012 [cited by applicant]
CN 102898284A · 2013 [cited by applicant]
CN 103003240A · 2013 [cited by applicant]
CN 103772138A · 2014 [cited by applicant]
CN 104045552A · 2014 [cited by applicant]
CN 104046369A · 2014 [cited by applicant]
CN 104058909A · 2014 [cited by applicant]
CN 104058993A · 2014 [cited by applicant]
CN 104059227A · 2014 [cited by applicant]
CN 104262071A · 2015 [cited by applicant]
CN 104817438A · 2015 [cited by applicant]
CN 105175202A · 2015 [cited by applicant]
CN 105198682A · 2015 [cited by applicant]
CN 103951632B · 2016 [cited by applicant]
CN 106146454A · 2016 [cited by applicant]
CN 106187656A · 2016 [cited by applicant]
CN 106905227A · 2017 [cited by applicant]
CN 107033149A · 2017 [cited by applicant]
CN 108484372A · 2018 [cited by applicant]
CN 108623439A · 2018 [cited by applicant]
CN 109293493A · 2019 [cited by applicant]
CN 109574853A · 2019 [cited by applicant]
CN 109796349A · 2019 [cited by applicant]
CN 110240593A · 2019 [cited by applicant]
CN 110683925A · 2020 [cited by applicant]
CN 112094165A · 2020 [cited by applicant]
CN 112552279A · 2021 [cited by applicant]
DE 3246493A1 · 1984 [cited by applicant]
DE 4323916A1 · 1995 [cited by applicant]
EP 1707263A1 · 2006 [cited by applicant]
EP 3051352A1 · 2016 [cited by applicant]
FR 2846656A1 · 2004 [cited by applicant]
GB 2095558A · 1982 [cited by applicant]
JP 05017433A · 1993 [cited by applicant]
JP 06321920A · 1994 [cited by examiner]
JP 2004189599A · 2004 [cited by applicant]
JP 2005330204A · 2005 [cited by applicant]
JP 2006036752A · 2006 [cited by applicant]
JP 2006151946A · 2006 [cited by applicant]
JP 2006305558A · 2006 [cited by applicant]
JP 2006306758A · 2006 [cited by applicant]
JP 2007121819A · 2007 [cited by applicant]
JP 2007147824A · 2007 [cited by applicant]
JP 2007187787A · 2007 [cited by applicant]
JP 2007199271A · 2007 [cited by applicant]
JP 2007206130A · 2007 [cited by applicant]
JP 2007238448A · 2007 [cited by applicant]
JP 2007248733A · 2007 [cited by applicant]
JP 2007256768A · 2007 [cited by applicant]
JP 2007316097A · 2007 [cited by applicant]
JP 2007316099A · 2007 [cited by applicant]
JP 2008050281A · 2008 [cited by applicant]
JP 2008115142A · 2008 [cited by applicant]
JP 2008203766A · 2008 [cited by applicant]
JP 2009023986A · 2009 [cited by applicant]
JP 2009298727A · 2009 [cited by applicant]
JP 2010138088A · 2010 [cited by applicant]
JP 2010208977A · 2010 [cited by applicant]
JP 2012201602A · 2012 [cited by applicant]
JP 2013023466A · 2013 [cited by applicant]
JP 2015020999A · 2015 [cited by applicant]
JP 2017002002A · 2017 [cited by applicant]
JP 2020158422A · 2020 [cited by applicant]
KR 20150136294A · 2015 [cited by applicant]
KR 20160087059A · 2016 [cited by applicant]
WO WO1991013546A1 · 1991 [cited by applicant]
WO WO1993010095A1 · 1993 [cited by applicant]
WO WO1995002580A2 · 1995 [cited by applicant]
WO WO1995004049A1 · 1995 [cited by applicant]
WO WO1996038567A2 · 1996 [cited by applicant]
WO WO1997049816A1 · 1997 [cited by applicant]
WO WO2002042275A1 · 2002 [cited by applicant]
WO WO2003019696A2 · 2003 [cited by applicant]
WO WO2003024222A1 · 2003 [cited by applicant]
WO WO2004002481A1 · 2004 [cited by applicant]
WO WO2004017920A2 · 2004 [cited by applicant]
WO WO2004055191A1 · 2004 [cited by applicant]
WO WO2005005382A2 · 2005 [cited by applicant]
WO WO2005020673A1 · 2005 [cited by applicant]
WO WO2005049620A1 · 2005 [cited by applicant]
WO WO2005060692A2 · 2005 [cited by applicant]
WO WO2005060956A1 · 2005 [cited by applicant]
WO WO2005062847A2 · 2005 [cited by applicant]
WO WO2005092326A1 · 2005 [cited by applicant]
WO WO2005107437A2 · 2005 [cited by applicant]
WO WO2006020358A2 · 2006 [cited by applicant]
WO WO2006025783A1 · 2006 [cited by applicant]
WO WO2006055625A2 · 2006 [cited by applicant]
WO WO2006058648A2 · 2006 [cited by applicant]
WO WO2006060634A2 · 2006 [cited by applicant]
WO WO2006076529A1 · 2006 [cited by applicant]
WO WO2006080884A1 · 2006 [cited by applicant]
WO WO2006084663A1 · 2006 [cited by applicant]
WO WO2006089221A2 · 2006 [cited by applicant]
WO WO2006107115A1 · 2006 [cited by applicant]
WO WO2006122926A1 · 2006 [cited by applicant]
WO WO2006136073A1 · 2006 [cited by applicant]
WO WO2007020381A2 · 2007 [cited by applicant]
WO WO2007038452A1 · 2007 [cited by applicant]
WO WO2007051408A1 · 2007 [cited by applicant]
WO WO2007052516A1 · 2007 [cited by applicant]
WO WO2007064809A2 · 2007 [cited by applicant]
WO WO2007082873A1 · 2007 [cited by applicant]
WO WO2007082878A1 · 2007 [cited by applicant]
WO WO2007082880A1 · 2007 [cited by applicant]
WO WO2007082882A1 · 2007 [cited by applicant]
WO WO2007095586A2 · 2007 [cited by applicant]
WO WO2007138089A1 · 2007 [cited by applicant]
WO WO2007142206A1 · 2007 [cited by applicant]
WO WO2008024963A1 · 2008 [cited by applicant]
WO WO2008037266A1 · 2008 [cited by applicant]
WO WO2008047707A1 · 2008 [cited by applicant]
WO WO2008051633A2 · 2008 [cited by applicant]
WO WO2008122603A2 · 2008 [cited by applicant]
WO WO2008150093A2 · 2008 [cited by applicant]
WO WO2008156656A2 · 2008 [cited by applicant]
WO WO2009025484A2 · 2009 [cited by applicant]
WO WO2009027679A1 · 2009 [cited by applicant]
WO WO2009101082A1 · 2009 [cited by applicant]
WO WO2009136646A1 · 2009 [cited by applicant]
WO WO2009144159A1 · 2009 [cited by applicant]
WO WO2009156359A2 · 2009 [cited by applicant]
WO WO2010072632A1 · 2010 [cited by applicant]
WO WO2010136144A1 · 2010 [cited by applicant]
WO WO2011085221A2 · 2011 [cited by applicant]
WO WO2011099832A2 · 2011 [cited by applicant]
WO WO2011160548A1 · 2011 [cited by applicant]
WO WO2012041789A1 · 2012 [cited by applicant]
WO WO2012059050A1 · 2012 [cited by applicant]
WO WO2012080975A1 · 2012 [cited by applicant]
WO WO2012125603A1 · 2012 [cited by applicant]
WO WO2013032907A1 · 2013 [cited by applicant]
WO WO2013093497A1 · 2013 [cited by applicant]
WO WO2013144628A1 · 2013 [cited by applicant]
WO WO2013155047A2 · 2013 [cited by applicant]
WO WO2014030090A1 · 2014 [cited by applicant]
WO WO2014186450A2 · 2014 [cited by applicant]
WO WO2015003146A1 · 2015 [cited by applicant]
WO WO2015022636A2 · 2015 [cited by applicant]
WO WO2015022639A2 · 2015 [cited by applicant]
WO WO2015022640A2 · 2015 [cited by applicant]
WO WO2015025960A1 · 2015 [cited by applicant]
WO WO2015054120A1 · 2015 [cited by applicant]
WO WO2015064326A1 · 2015 [cited by applicant]
WO WO2015071087A1 · 2015 [cited by applicant]
WO WO2015082411A1 · 2015 [cited by applicant]
WO WO2015092706A1 · 2015 [cited by applicant]
WO WO2015115556A1 · 2015 [cited by applicant]
WO WO2015134973A1 · 2015 [cited by applicant]
WO WO2015191988A1 · 2015 [cited by applicant]
WO WO2016051193A1 · 2016 [cited by applicant]
WO WO2016203377A1 · 2016 [cited by applicant]
WO WO2017023778A1 · 2017 [cited by applicant]
WO WO2017039969A1 · 2017 [cited by applicant]
WO WO2017087672A1 · 2017 [cited by applicant]
WO WO2017112589A1 · 2017 [cited by applicant]
WO WO2017174207A1 · 2017 [cited by applicant]
WO WO2017198859A1 · 2017 [cited by applicant]
WO WO2018019860A1 · 2018 [cited by applicant]
WO WO2018022777A1 · 2018 [cited by applicant]
WO WO2019106156A1 · 2019 [cited by applicant]
WO WO2020097408A1 · 2020 [cited by applicant]
WO WO2020226150A1 · 2020 [cited by applicant]
WO WO2020247747A1 · 2020 [cited by applicant]
WO WO2021049470A1 · 2021 [cited by applicant]
WO WO2021096241A1 · 2021 [cited by applicant]
WO WO2023001679A1 · 2023 [cited by applicant]
WO WO2023044364A1 · 2023 [cited by applicant]
Patani et al. (Chem. Rev., 1996, 96(8), 3043-3350). [cited by examiner]
Koyanagi (Ch. 2: Bioisosterism in Agrochemicals, 1995, Baker et al. Syn. and Chem. Of Agrochemicals IV, p. 15-24). [cited by examiner]
Pioneer (https://web.archive.org/web/20200927035343/https://www.pioneer.com/us/agronomy/ppo-inhibitor-herbicides.html). [cited by examiner]
Korenaga et al. (Org. Lett., 2005, 7(22), 4915-4917, including supporting information). [cited by examiner]
CAS Registry No. 1261619-22-0 which entered registry on Feb. 2, 2011. [cited by examiner]
CAS Registry No. 1261861-93-1 which entered registry on Feb. 3, 2011. [cited by examiner]
Honda et al., (2008). “Synthesis of novel 1,4-benzoxazin-3-one derivatives as inhibitors against tyrosine kinases,” Bioorganic & Medicinal Chemistry, 17(2):699-708. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2023/060448 mailed on Jun. 14, 2023, 14 pages. [cited by applicant]
Pubchem, (2005). “CID: 3239077; (6-methyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4- yl)acetic acid,” available online at <https://pubchem.ncbi.nlm.nih.gov/compound/3239077#section=Patents>, 13 pages. [cited by applicant]
Pubchem, (2015). “CID: 102415219; 6-(Pentafluorophenyl)tetralin,” available online at <https://pubchem.ncbi.nlm.nih.gov/compound/102415219>, 9 pages. [cited by applicant]
Shukla et al., (2009). “Precise genome modification in the crop species [cited by applicant]
Sicker et al., (2000). “Role of Natural Benzoxazinones in the Survival Strategy of Plants,” International Review of Cytology, 198:319-346. [cited by applicant]
Artamkina et al., (1998). “The Reaction of the [CpFe(CO)2]-Anion with Pentafluorochlorobenzene: Nucleophilic Aromatic Substitution by Halogen-Metal Exchange,” A European Journal, 4(7):1169-1178. Abstract Only. [cited by applicant]
Breslin et al., (2012). “Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19, 13]docosa-1(20), 3(22),4,6,9(21), 10, 12, 16, 18-non… [cited by applicant]
Chen et al., (2005). “Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors,” Bioorganic & medicinal Chemistry, 13(7):2459-2468. [cited by applicant]
DiMauro et al., (2016). “Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective Nav1.7 Inhibitors,” Journal of Medicinal Chemistry, 59(17):7818-7839. Abstrac… [cited by applicant]
Fernandez-Moreno et al., (2018). “Abstract: A Novel Amino Acid Substitution (Arg-132-His) In Protoporphyrinogen Oxidase 2 Confers Broad Spectrum Ppo-Inhibitor Resistance In Lolium Rigidum,” Weed Science Society of Ameri… [cited by applicant]
Fu et al., (2014). “Hot Fusion: An Efficient Method to Clone Multiple DNA Fragments as Well as Inverted Repeats without Ligase,” PLoS One, 9(12):e115318, 20 pages. [cited by applicant]
Giacomini et al., (2017). “Two New PPX2 Mutations Associated with Resistance to PPO-Inhibiting Herbicides in Amaranthus palmeri,” Pest Management Science, 73:1559-1563, 16 pages. [cited by applicant]
Hao et al., (2011). “Protoporphyrinogen oxidase inhibitor: an ideal target for herbicide discovery,” Chimia, 65(12):961-969. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2022/076458 mailed on Dec. 8, 2022, 14 pages. [cited by applicant]
Jacobs et al., (1982). “Assay for enzymatic protoporphyrinogen oxidation, a late step in heme-synthesis,” Enzyme, 28:206-217. [cited by applicant]
Jiang et al., (2013). “Grafting Imparts Glyphosate Resistance in Soybean,” Weed Technology, 27:412-416. [cited by applicant]
Lee et al., (1993). “Cellular Localization of Protoporphyrinogen-Oxidizing Activities of Etiolated Barley ( [cited by applicant]
Li et al., (2005). “Development of PPO inhibitor-resistant cultures and crops,” Pest Management Science, 61:277-285. Abstract Only. [cited by applicant]
Lin et al., (1977). “Decomposition and byproducts from reactions involving pentafluorophenyl-grignard and lithium reagents. a GC/MS study,” Journal of Fluorine Chemistry, 9(2):161-9. Abstract Only. [cited by applicant]
Matringe et al., (1989). “Protoporphyrinogen oxidase as a molecular target for diphenyl ether herbicides,” Biochemistry Journal, 260(1):231-235. [cited by applicant]
Nikul'shin et al., (2021). “Synthesis of Bromochloropolyfluorobiphenyls Containing Bromine and Chlorine Atoms in the 4 and 4,4′ Positions,” Russian Journal of General Chemistry, 91(7):1316-1324. 10 pages. Abstract Only. [cited by applicant]
Patzoldt et al., (2006). “A codon deletion confers resistance to herbicides inhibiting protoporphyrinogen oxidase,” Proc. Natl. Acad. Sci. USA, 103:12329-12334. [cited by applicant]
Rangani et al., (2018). “A Novel Mutation in Protoporphyrinogen Oxidase IX (PPO) Confers Broad Resistance to PPO inhibitors,” Weed Science Society of America (WSSA) annual meeting, 1 page. [cited by applicant]
Rousonelos et al., (2012). “Characterization of a common ragweed ( [cited by applicant]
Shoup et al., (2003). “Common waterhemp ( [cited by applicant]
Albericio et al., (2018). “Choosing the Right Coupling Reagent for Peptides: A Twenty-Five-Year Journey,” Organic Process Research & Development, 22(7):760-772, 44 pages. [cited by applicant]
Bollu et al., (2022). “Surveying the Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-ones and Related Analogs,” International Journal of Science and Research, 11(5):427-432. [cited by applicant]
Extended European Search Report and Written Opinion received for European Patent Application No. 22870942.4 mailed on Jun. 3, 2025, 8 pages. [cited by applicant]
Hollanders et al., (2019). “A New Wave of Amide Bond Formations for Peptide Synthesis,” Synthesis, 51(11):2261-2277, 30 pages. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2024/019775 mailed on Jun. 27, 2024, 9 pages. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2024/029309 mailed on Aug. 15, 2024, 14 pages. [cited by applicant]
N'Guessan et al., (2022). “Herbicidal Analogs of Cycloalka[d]quinazoline-2,4-dione-Benzoxazinones Inhibiting Protoporphyrinogen IX Oxidase,” Journal of Pharmaceutical Research International, 34(56):42-61. [cited by applicant]
Pubchem, (2023). “CID: 167523803; 2-bromo-N:(5-bromo-4-fluoros2-hydroxyphenyl}-2,2-difluoroacetamide,” available online at <https://pubchem.ncbi.nlm.nih.gov/compound/167523803>, 9 pages. [cited by applicant]
Pubchem, (2023). “CID: 37329; 2,2,2-Trifluoro-N-(4-fluorophenyl)acetamide,” available online at <https://pubchem.ncbi.nlm.nih.gov/compound/37329>, 25 pages. [cited by applicant]
Pubchem, (2007). “CID: 18670061; N-(3,4-diiodophenyl)-2,2,2-trifluoroethanamide,” available online at <https://pubchem.ncbi.nlm.nih.gov/compound/18670061>, 10 pages. [cited by applicant]
Pubchem, (2023). “CID: 167523754; 2,2,7-trifluoro-6-(2,3,4,5,6-pentafluorophenyl)-4H-1,4-benzoxazin-3-one,” available online at <https://pubchem.ncbi.nlm.nih.gov/compound/167523754>, 9 pages. [cited by applicant]
Extended European Search Report and Written Opinion received for European Patent Application No. 23740778.8 mailed on Nov. 21, 2025, 8 pages. [cited by applicant]